| Autor: |
Wei, Qi, Mease, Philip J, Chiorean, Michael, Iles-Shih, Lulu, Matos, Wanessa F, Baumgartner, Andrew, Molani, Sevda, Hwang, Yeon Mi, Belhu, Basazin, Ralevski, Alexandra, Hadlock, Jennifer |
| Zdroj: |
The Lancet Digital Health; May 2024, Vol. 6 Issue: 5 pe309-e322, 14p |
| Abstrakt: |
In the context of immune-mediated inflammatory diseases (IMIDs), COVID-19 outcomes are incompletely understood and vary considerably depending on the patient population studied. We aimed to analyse severe COVID-19 outcomes and to investigate the effects of the pandemic time period and the risks associated with individual IMIDs, classes of immunomodulatory medications (IMMs), chronic comorbidities, and COVID-19 vaccination status. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
